has produced a device that uses sound waves to treat tissue in lieu of invasive surgery. Clinical trials have been set for patients with urinary problems due to an enlarged prostate. Pretty cool, huh?
"Christine Gibbons, HistoSonics president and chief operating officer, said the Vortx Rx was approved for investigational use in clinical trials on humans in May by the U.S. Food and Drug Administration and Health Canada. Clinical trials began in July to treat patients with urinary problems due to an enlarged prostate. The trial phase is expected to last several years. The discovery and development work on the technology was performed at the University of Michigan.
Six units were made, three of which are being used for clinical trials at sites in Michigan, Ohio and Ontario. The hope is the device will be used for other clinical indications beyond urology."
Enjoy this story? Sign up
for free solutions-based reporting in your inbox each week.